Myriad Genetics, OptraHEALTH Partner to Offer Cancer Knowledge

 | Jul 07, 2020 06:32AM ET

Myriad Genetics (NASDAQ:MYGN), Inc. industry ’s 17.4% growth and the S&P 500’s 16.1% rise.